Phase 4 RCT in 150 adults with active rheumatoid arthritis and inadequate methotrexate response: ultrasound synovitis response at week 12 with baricitinib, alone or with MTX, was noninferior to etanercept plus MTX.
RCTn = 150
Naredo et al. Response of ultrasound-assessed synovitis to baricitinib, in monotherapy and combined with methotrexate, compared with etanercept in rheumatoid arthritis: a randomised, international, multicentre trial